Characteristics of Women in the United States Who Use Long-Acting Reversible Contraceptive Methods

2011 ◽  
Vol 117 (6) ◽  
pp. 1349-1357 ◽  
Author(s):  
Megan L. Kavanaugh ◽  
Jenna Jerman ◽  
David Hubacher ◽  
Kathryn Kost ◽  
Lawrence B. Finer
Keyword(s):  
United States ◽  
The United States ◽  
Contraceptive Methods ◽  
Long Acting ◽  
Long Acting Reversible Contraceptive

Who uses long-acting reversible contraceptive methods in the United States?

Contraception ◽  
2011 ◽  
Vol 84 (3) ◽  
pp. 317
Author(s):  
M. Kavanaugh ◽  
J. Jerman ◽  
D. Hubacher ◽  
K. Kost ◽  
L. Finer
Keyword(s):  
United States ◽  
The United States ◽  
Contraceptive Methods ◽  
Long Acting ◽  
Long Acting Reversible Contraceptive

Contraception in Adolescents

2021 ◽  
Author(s):  
Shandhini Raidoo ◽  
Marit Pearlman Shapiro ◽  
Bliss Kaneshiro
Keyword(s):  
Contraceptive Use ◽  
Unwanted Pregnancy ◽  
Healthcare Providers ◽  
The United States ◽  
Sexually Active ◽  
Contraceptive Methods ◽  
Contraceptive Counseling ◽  
Unscheduled Bleeding ◽  
Long Acting ◽  
Long Acting Reversible Contraceptive

AbstractAdolescents are at risk for unwanted pregnancy when they become sexually active, and contraception is an important part of mitigating this risk. Use of contraceptive methods, and long-acting reversible contraceptive methods such as implants and intrauterine devices in particular, has increased among adolescents. Although sexual activity has declined and contraceptive use has increased among adolescents in the United States in recent years, the unintended pregnancy rate remains high. All of the currently available contraceptive methods are safe and effective for adolescents to use; however, adolescents may have specific concerns about side effect profiles and unscheduled bleeding that should be addressed during contraceptive counseling. Healthcare providers should prioritize adolescents' needs and preferences when approaching contraceptive counseling, and also consider the unique access and confidentiality issues that adolescents face when accessing contraception.

scholarly journals Changes in use of long-acting contraceptive methods in the United States, 2007–2009

2012 ◽  
Vol 98 (4) ◽  
pp. 893-897 ◽  
Author(s):  
Lawrence B. Finer ◽  
Jenna Jerman ◽  
Megan L. Kavanaugh
Keyword(s):  
United States ◽  
The United States ◽  
Contraceptive Methods ◽  
Long Acting

Access and Use of Contraception and Its Effects on Women’s Outcomes in the United States

2017 ◽  
pp. 218-258 ◽  
Author(s):  
Martha J. Bailey ◽  
Jason M. Lindo
Keyword(s):  
United States ◽  
Birth Control ◽  
The United States ◽  
Human Existence ◽  
Economic Outcomes ◽  
Birth Control Pill ◽  
American Women ◽  
Long Acting ◽  
Long Acting Reversible Contraceptives

Changes in childbearing affect almost every aspect of human existence. Over the last fifty years, American women have experienced dramatic changes in the ease and convenience of timing and limiting childbearing, ranging from the introduction of the birth control pill and the legalization of abortion to more recent availability of long-acting reversible contraceptives (LARCs). This chapter chronicles these changes, provides descriptive evidence regarding trends in the use of contraception and abortion, and reviews the literature linking them to changes in childbearing and women’s economic outcomes. It concludes by discussing the recent surge in LARC use, which seems to be one of the most pressing areas in need of further research.

Warning against long-acting sulphonamides

1966 ◽  
Vol 4 (4) ◽  
pp. 13-13
Keyword(s):  
United States ◽  
Mortality Rate ◽  
Erythema Multiforme ◽  
The United States ◽  
Stevens Johnson Syndrome ◽  
Warning Letter ◽  
Johnson Syndrome ◽  
The Us ◽  
Mucous Membranes ◽  
Long Acting

Last month the US Food and Drug Administration required American manufacturers of long-acting sulphonamides (sulphamethoxypyridazine, Lederkyn - Lederle and Midicel - PD; sulphadimethoxine - Madribon - Roche) to warn prescribers that in rare cases the Stevens-Johnson syndrome may develop as a severe and sometimes fatal side effect. This syndrome is a type of erythema multiforme in which large blisters appear on the skin and especially on the mucous membranes. The manufacturers were also to advise doctors ‘to consider prescribing short-acting sulphonamides first because they are effective for most of the same conditions’. The three drug firms concerned accordingly sent a joint warning letter to all doctors, pointing out that the Stevens-Johnson syndrome is a serious complication with a mortality rate of about 25%. So far 116 cases of this syndrome have been reported in association with the use of long-acting sulphonamides, most of them in the United States. Almost two thirds of the patients were children.

Sign in / Sign up

Export Citation Format

Share Document